CRDF
Cardiff Oncology Inc
$4.18
Earnings Summary
Revenue | $0.16Mn |
Net Profits | $-9.34Mn |
Net Profit Margins | -5985.26% |
Highlights
Cardiff Oncology Inc’s revenue jumped 21.88% since last year same period to $0.16Mn in the Q4 2023. On a quarterly growth basis, Cardiff Oncology Inc has generated 10.64% jump in its revenue since last 3-months.
Cardiff Oncology Inc’s net profit fell -16.68% since last year same period to $-9.34Mn in the Q4 2023. On a quarterly growth basis, Cardiff Oncology Inc has generated 4.05% jump in its net profits since last 3-months.
Cardiff Oncology Inc’s net profit margin jumped 4.26% since last year same period to -5985.26% in the Q4 2023. On a quarterly growth basis, Cardiff Oncology Inc has generated 13.27% jump in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
Earnings per share (EPS) estimates of the Cardiff Oncology Inc post its latest quarter earnings
EPS Estimate Current Quarter | -0.25 |
EPS Estimate Current Year | -0.25 |
Highlights
Cardiff Oncology Inc’s earning per share (EPS) estimates for the current quarter stand at -0.25 - a 10.71% jump from last quarter’s estimates.
Cardiff Oncology Inc’s earning per share (EPS) estimates for the current year stand at -0.25.
Key Ratios
Key ratios of the Cardiff Oncology Inc post its Q4 2023 earnings
Earning Per Share (EPS) | -0.21 |
Highlights
Cardiff Oncology Inc’s earning per share (EPS) fell -5% since last year same period to -0.21 in the Q4 2023. This indicates that the Cardiff Oncology Inc has generated -5% annual rate of fall in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2024-02-29 | -0.28 | -0.21 | 25% |
2023-11-02 | -0.28 | -0.22 | 21.43% |
2023-05-04 | -0.23 | -0.25 | -8.7% |
2023-08-09 | -0.26 | -0.25 | 3.85% |
₹0 US Stocks a/c Opening Fee